European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“Episode 1 of Innovations in Oncology: Understanding Novel and Emerging Immunotherapies is now live on OncologyPro!
Our hosts Lavinia Spain, Victoria Atkinson, and Emanuela Romano are joined by John B.A.G. Haanen from the Netherlands Cancer Institute, Amsterdam, for a fascinating discussion on TIL and TCR-T cell therapies.
Available now in both audio and video on OncologyPro – don’t miss it!
Have a question on this topic? Leave a comment and our hosts may address it in a future episodes.”
Other articles featuring ESMO on OncoDaily.